Related Experiment Videos

Cholinergic urticaria successfully treated with scopolamine butylbromide

Yuichiro Tsunemi, Hironobu Ihn, Hidehisa Saeki

International Journal of Dermatology

|October 3, 2003

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study.

The Journal of dermatology·2026

Real-World Effectiveness of Tildrakizumab in Japanese Patients With Psoriasis: Analyses Stratified by Prior Systemic Therapy, Maintenance of Early Responses, and Achievement of Delayed Responses.

The Journal of dermatology·2026

New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review.

Dermatology and therapy·2026

Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study).

The Journal of dermatology·2026

Effectiveness, biomarker transition, and safety of 48-week tralokinumab treatment for atopic dermatitis: real-world analyses stratified by age groups (15-17, 18-64, and ≥ 65 years).

European journal of dermatology : EJD·2026

Long-term outcomes after switching from baricitinib 4 mg to upadacitinib 30 mg in atopic dermatitis: A 144-week retrospective study.

Journal of the American Academy of Dermatology·2026

See all related articles